Similar Articles
Complete Recovery in Cryptogenic NORSE with Early Immunotherapy: A Case Report
Türkan Acar, Sena Boncuk, Bilgehan Acar, Yeşim Güzey Aras
DOI: 10.4274/tnd.2020.01879
Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
Beuy Joob, Viroj Wowanitkit
DOI: 10.4274/tnd.2020.99897
Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability
Hatice Ayan, Özge Ertekin, Turhan Kahraman, Serkan Özakbaş
DOI: 10.4274/tnd.2020.36036
A Multifaceted Evaluation of National Off-label Neurology Applications
Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe
DOI: 10.4274/tnd.2020.37791
Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi
DOI: 10.4274/tnd.2020.45467
Awareness of Stroke in the Population Presenting to Outpatient Clinics at a Tertiary Health Institution
Buket Tuğan Yıldız, Mustafa Gökçe, Hamza Şahin
DOI: 10.4274/tnd.2020.47887
The Role of Neurologist in the Assessment and Treatment of Depression
Emre Kumral, Fatma Ece Bayam
DOI: 10.4274/tnd.2019.44341
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Damla Çetinkaya, Seher Naz Yeni
DOI: 10.4274/tnd.2019.22755
Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak
DOI: 10.4274/tnd.2019.34392
Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy
DOI: 10.4274/tnd.2019.77010
Neuroprotective Treatments in Parkinson’s Disease
Elif Çınar, Gul Yalçın Çakmaklı, Banu Cahide Tel
DOI: 10.4274/tnd.2019.01205
The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu
DOI: 10.4274/tnd.2019.09735
Predictors of Mortality in Patients with Surgically Treated Spontaneous Intracranial Hemorrhage
İsmail Kaya, İlker Deniz Cingöz, İnan Uzunoğlu, Ceren Kızmazoğlu, Hasan Emre Aydın, Nurullah Yüceer
DOI: 10.4274/tnd.2019.67365
Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler
DOI: 10.4274/tnd.2019.33341
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk
DOI: 10.4274/tnd.2019.93206
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
Bahar Say, Ufuk Ergün
DOI: 10.4274/tnd.2019.87513
Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes
İpek Güngör Doğan
DOI: 10.4274/tnd.2019.97720
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Halil Önder
DOI: 10.4274/tnd.2019.05925